The Latest Breaking News from Disease

US cases of plague are exceedingly rare, and modern therapies are effective when patients are treated in time

An existing drug for the chronic disease could slow or stop its progression, researchers say

Family videos and self-shot footage provide an intimate, moving chronicle of the lives of former Chilean government minister Paulina Urrutia and her ex-journalist husband

New research has shown that disease-causing bacteria carried in the human gut can also survive in Martian soil, a discovery with implications for future crewed exploration of Mars.

The pharmaceutical industry is thriving due to the growing demand for quality healthcare and high-quality drugs, a rapidly aging population, and the rise in chronic diseases. To capitalize on the industry’s growth prospects, investors could consider buying fundamentally strong pharma stocks Amphastar Pharmaceuticals (AMPH), Bausch Health Companies (BHC), and ACADIA…

Officials say disease, which killed millions in medieval Europe, was identified and treated early, ‘posing little risk to the community’

Dr Durrheim says the whooping cough vaccine is life saving.

Swimming in contaminated water usually causes the disease.

Parents are being urged to isolate ill kids and keep them out of pools after more than 500 children aged under 10 were diagnosed with a diarrhoeal disease.

Oregon saw its first human case of bubonic plague in eight years, and officials suspect the infected person's cat sickened them.

With an increasing demand for treatments of chronic diseases, heightened investments in research and development, and the widespread integration of technology, the pharma industry is primed for success. Amid the solid industry prospects, let’s analyze the gain potential of three pharma stocks: Amneal Pharmaceuticals (AMRX), AbbVie Inc. (ABBV), and GSK…